Darunavir · more major-labeled pairs than Sofosbuvir/Velpatasvir

SPL labels Sofosbuvir/Velpatasvir + Darunavir as minor; Sofosbuvir/Velpatasvir 20 / Darunavir 70 in that band.

Mechanism on file: Research indicates that there is no important interaction between these two medications. They do not interfere with each other's levels in the blood.

FDA SPL severity: Minor

Sofosbuvir/Velpatasvir

Full Sofosbuvir/Velpatasvir label record

NS5B/NS5A Inhibitor (HCV)

Darunavir

Full Darunavir label record

HIV Protease Inhibitor

Sofosbuvir/Velpatasvir + Darunavir · SPL mechanism field

Research indicates that there is no important interaction between these two medications. They do not interfere with each other's levels in the blood.

Minor band excerpt · Sofosbuvir/Velpatasvir with Darunavir

7.4 Drugs without Clinically Significant Interactions with VOSEVI Based on drug interaction studies conducted with the components of VOSEVI (sofosbuvir, velpatasvir, and/or voxilaprevir) or VOSEVI, no clinically significant drug interactions have been observed with the following drugs [see Clinical Pharmacology (12.3) ]: VOSEVI: cobicistat, darunavir, elvitegravir, emtricitabine, ethinyl estradiol/norgestimate, gemfibrozil, rilpivirine, ritonavir, tenofovir alafenamide, voriconazole Sofosbuvir/velpatasvir: dolutegravir, ketoconazole, raltegravir Sofosbuvir: methadone, tacrolimus

Darunavir · 15 major-labeled pairs (vs Sofosbuvir/Velpatasvir's 3)

View all Darunavir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.